Loading…
Based on limited metadata, this FDA Warning Letter issued to Torrent Pharmaceuticals Limited on October 8, 2019, addresses compliance issues related to drug manufacturing or operations. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined, though they fall under FDA's drug product oversight. The warning indicates the agency identified concerns significant enough to warrant formal regulatory action against this pharmaceutical manufacturer, though the specific issuing office and detailed violation categories are not available in this summary record.